Health-related quality of life (HrQoL) of first-line treatments in metastatic renal cell carcinoma (mRCC): A network meta-analysis

被引:0
|
作者
Abidoye, Oluseyi
Naqvi, Syed Arsalan Ahmed
Faisal, Kunwer Sufyan
Imran, Manal
Khakwani, Kaneez Zahra Rubab
Raina, Ammad
Tripathi, Nikita
Abdul-Muhsin, Haidar
Costello, Brian Addis
Singh, Parminder
Bryce, Alan Haruo
Riaz, Irbaz Bin
机构
[1] Mayo Clin Arizona, Phoenix, AZ USA
[2] Mayo Clin, Div Hematol & Med Oncol, Phoenix, AZ USA
[3] Ziauddin Med Univ, Karachi, Pakistan
[4] Dow Med Coll, Karachi, Pakistan
[5] Univ Arizona, Tucson, AZ USA
[6] Canyon Vista Med Ctr, Sierra Vista, AZ USA
[7] Mayo Clin, Rochester, MN USA
[8] Mayo Clin, Phoenix, AZ USA
[9] Mayo Clin Arizona, Scottsdale, AZ USA
[10] Mayo Clin, Div Hematol & Oncol, Scottsdale, AZ USA
关键词
D O I
10.1200/JCO.2024.42.4_suppl.412
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:412 / 412
页数:1
相关论文
共 50 条
  • [1] Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysis
    Cattrini, Carlo
    Messina, Carlo
    Airoldi, Chiara
    Buti, Sebastiano
    Roviello, Giandomenico
    Mennitto, Alessia
    Caffo, Orazio
    Gennari, Alessandra
    Bersanelli, Melissa
    THERAPEUTIC ADVANCES IN UROLOGY, 2021, 13
  • [2] First-line antiangiogenics for metastatic renal cell carcinoma: A systematic review and network meta-analysis
    Rousseau, Benoit
    Kempf, Emmanuelle
    Desamericq, Gaelle
    Boissier, Emilie
    Chaubet-Houdu, Marie
    Joly, Charlotte
    Saldana, Carolina
    Boussion, Helene
    Neuzillet, Cindy
    Macquin-Mavier, Isabelle
    Oudard, Stephane
    Salomon, Laurent
    de la Taille, Alexandre
    Tournigand, Christophe
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 107 : 44 - 53
  • [3] Optimal First-Line Treatment of Metastatic Renal-Cell Carcinoma: A Network Meta-Analysis
    Hahn, Andrew W.
    Hale, Peter
    Maughan, Benjamin L.
    Haaland, Benjamin
    Agarwal, Neeraj
    KIDNEY CANCER, 2018, 2 (02) : 115 - 121
  • [4] First-line Treatment of Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis
    Hahn, Andrew W.
    Klaassen, Zachary
    Agarwal, Neeraj
    Haaland, Benjamin
    Esther, John
    Ye, Xiang Y.
    Wang, Xuechen
    Pal, Sumanta K.
    Wallis, Christopher J. D.
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (06): : 708 - 715
  • [5] Efficacy and Safety of Approved First-Line Tyrosine Kinase Inhibitor Treatments in Metastatic Renal Cell Carcinoma: A Network Meta-Analysis
    Kirsi M. Manz
    Klaus Fenchel
    Andreas Eilers
    Jonathan Morgan
    Kirsten Wittling
    Wolfram C. M. Dempke
    Advances in Therapy, 2020, 37 : 730 - 744
  • [6] Efficacy and Safety of Approved First-Line Tyrosine Kinase Inhibitor Treatments in Metastatic Renal Cell Carcinoma: A Network Meta-Analysis
    Manz, Kirsi M.
    Fenchel, Klaus
    Eilers, Andreas
    Morgan, Jonathan
    Wittling, Kirsten
    Dempke, Wolfram C. M.
    ADVANCES IN THERAPY, 2020, 37 (02) : 730 - 744
  • [7] A framework for living evidence synthesis in cancer: Living, interactive network meta-analysis for first-line treatment of metastatic renal cell carcinoma (mRCC).
    Bin Riaz, Irbaz
    He, Huan
    Ryu, Alexander J.
    Siddiqi, Rabbia
    Naqvi, Syed Arsalan Ahmed
    Yao Yuan
    Husnain, Muhammad
    Maheswari, Deepa
    Sipra, Qurat Ul Ain Riaz
    Montori, Victor
    Joseph, Richard Wayne
    Liu Hongfang
    Wang Zhen
    Herasevich, Vitaly
    Singh, Parminder
    Ho, Thai Huu
    Bryce, Alan Haruo
    Pagliaro, Lance C.
    Murad, Hassan M.
    Costello, Brian Addis
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [8] First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis
    Wallis, Christopher J. D.
    Klaassen, Zachary
    Bhindi, Bimal
    Ye, Xiang Y.
    Chandrasekar, Thenappan
    Farrell, Ann M.
    Goldberg, Hanan
    Boorjian, Stephen A.
    Leibovich, Bradley
    Kulkarni, Girish S.
    Shah, Prakesh S.
    Bjarnason, Georg A.
    Heng, Daniel Y. C.
    Satkunasivam, Raj
    Finelli, Antonio
    EUROPEAN UROLOGY, 2018, 74 (03) : 309 - 321
  • [9] UPDATED NETWORK META-ANALYSIS OF TREATMENTS IN FIRST-LINE ADVANCED/METASTATIC INTERMEDIATE- OR POOR-RISK RENAL CELL CARCINOMA
    Cakar, E.
    May, J.
    Malcolm, B.
    Gooden, K. M.
    Klijn, S.
    VALUE IN HEALTH, 2019, 22 : S439 - S439
  • [10] A NETWORK META-ANALYSIS OF EFFICACY OF FIRST-LINE AND SECOND-LINE THERAPIES FOR THE MANAGEMENT OF METASTATIC RENAL CELL CARCINOMA
    Heo, J. H.
    Park, C.
    Zivkovic, M.
    VALUE IN HEALTH, 2019, 22 : S56 - S56